Searched for
NEW ANTIVIRAL DRUGS
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- New study finds link between Covid antiviral drug & virus mutationsA study published in the journal Nature has found a link between the COVID-19 antiviral drug molnupiravir and a pattern of mutations in the...
- Early metformin use may cut Covid hospitalisation, death risk by half: StudyThe researchers from the University of Minnesota noted that metformin has been used in the 1950s as an anti-viral called "Fluamine."
- Neem tree extract can help treat Covid & reduce its spread, says new studyThe study shows that the components of Neem bark may target a wide range of viral proteins.
- New antiviral drug combo highly effective against COVID-19: Study"Identifying combinations of antivirals is really important, not only because doing so may increase the drugs' potency against the coronavi...
- Covid cases on the rise, experts call for newer drugs, faster approvalsThe Drug Controller General of India had last week approved Merck and Ridgeback’s antiviral molnupiravir for the treatment of mild-to-moder...
- Pfizer pill becomes 1st US-authorized home COVID treatmentData from Pfizer's clinical trial showed its two-drug antiviral regimen was 90% effective in preventing hospitalizations and deaths in pati...
- Merck v Pfizer: here's how the two new COVID antiviral drugs work and will be usedUK approved molnupiravir, the COVID antiviral developed by Merck and Ridgeback Therapeutics. Now, Pfizer has released results from trials o...
- Local firms gear up to seek licence for Pfizer's Covid drugUS drug giant Pfizer on Tuesday announced a deal with MPP - a UN-backed public health organization - to issue royalty-free voluntary licenc...
- Indian pharma eyes affordable antiviral medicines to treat Covid-19The coronavirus is headed to the endemic stage in certain countries, giving these new drugs a potentially huge market, along with the abili...
- Aurobindo Pharma, MSN Labs seek DGCI nod for Phase-III trials of Merck's molnupiravirIn a meeting held on October 4, both the companies said that they “they want to discontinue phase III trial in moderate Covid-19 patients a...
- A new oral antiviral drug for COVID-19 is being tested in humans - can it make a difference?One promising drug that could improve things is molnupiravir, an antiviral that's moving into the final stages of testing in humans. Resear...
- Remdesivir production increased to 1.05 cr vials a month: Mansukh MandaviyaThe production capacity of the drug has crossed 1.05 crore vials per month as on May 4, a nearly three-fold increase from 37 lakh vials per...
- Do not neglect anti-Covid drugsAs the virus continues to mutate, vaccines developed for previous versions might cease to be effective. Antiviral drugs are, therefore, gai...
- Potential antiviral drug against Covid-19 identified, scientists say it's 'highly effective'It triggers a response against three major types of human respiratory viruses, including Covid.
- India to seek latest data on efficacy of Gilead’s Remdesivir following USFDA nodThe FDA had granted remdesivir emergency authorisation in May after a trial by the National Institutes of Health found that it modestly red...
- Breakthrough in chikungunya may come from IIT-RoorkeeRoorkee, Oct 5 (IANS) In a move that could lead to a breakthrough in combating chikungunya, the Indian Institute of Technology (IIT)-Roorke...
- Zydus Cadila gets USFDA nod for anti-viral drugAcylovir for injection USP caters to the anti-viral segment, the company said adding that it will be produced at the group's formulations m...
Load More
